Get the Stockscreener App
2.84
1.05%
-0.03
Affimed N V Stock (AFMD) Latest News
Affimed Q3 2024 Earnings Preview - MSN
Is Affimed N.V. (AFMD) the Best German Stock to Buy Now? - Insider Monkey
10 Best German Stocks To Buy Now - Insider Monkey
Affimed's (AFMD) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat
Affimed N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Stifel Nicolaus Cuts Affimed (NASDAQ:AFMD) Price Target to $4.00 - MarketBeat
Affimed N.V. (NASDAQ:AFMD) Q3 2024 Earnings Call Transcript - Insider Monkey
Affimed's (AFMD) Buy Rating Reiterated at HC Wainwright - MarketBeat
Earnings call: Affimed reports promising results and strategic focus - Investing.com India
Affimed NV (AFMD) Q3 2024 Earnings Call Highlights: Navigating F - GuruFocus.com
Affimed NV (AFMD) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges with ... - Yahoo Finance
Affimed Reports Q3 2024 Financial Results and Updates - TipRanks
Affimed N.V.: Q3 Earnings Snapshot - Houston Chronicle
Affimed NV earnings missed by €0.09, revenue fell short of estimates - Investing.com Canada
Affimed Faces Growing Losses Amid Financial Struggles - TipRanks
Affimed Reports Third Quarter 2024 Financial Results & Business Update - The Manila Times
Affimed Q3 Revenue Drops 90%, but Net Loss Narrows as R&D Costs Decline | AFMD Stock News - StockTitan
Affimed (AFMD) Scheduled to Post Quarterly Earnings on Thursday - Defense World
Affimed to Report Third Quarter 2024 Financial Results and Corporate Update on November 14, 2024 - Marketscreener.com
Affimed (AFMD) Scheduled to Post Earnings on Thursday - MarketBeat
Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024 - GlobeNewswire
Affimed (AFMD) Sets Q3 2024 Earnings Call for Nov 14: Immuno-Oncology Updates Ahead | AFMD Stock News - StockTitan
Affimed (NASDAQ:AFMD) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Affimed Announces Acceptance of Three Abstracts at the 2024 - GlobeNewswire
Affimed to Present Promising AML Treatment Data at ASH 2024 Annual Meeting | AFMD Stock News - StockTitan
Affimed (NASDAQ:AFMD) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Affimed (NASDAQ:AFMD) Given Average Rating of “Buy” by Analysts - Defense World
Affimed (NASDAQ:AFMD) Short Interest Update - MarketBeat
683 Capital Management, LLC Expands Stake in Affimed NV - Yahoo Finance
Affimed Appoints New Director Amid Strategic Moves - TipRanks
Affimed N : Annual General Meeting Results Form 6 K - Marketscreener.com
Affimed N : Presentation - Marketscreener.com
Analysts Set Affimed (NASDAQ:AFMD) Target Price at $20.00 - MarketBeat
Affimed Appoints New CEO, Shares Fall on Leadership Change - MSN
Affimed appoints Shawn Leland as chief executive officer - MSN
Affimed (NASDAQ:AFMD) Sees Significant Decrease in Short Interest - MarketBeat
AFMDAffimed N.V. Latest Stock News & Market Updates - StockTitan
Affimed N.V. Announces Upcoming EGM - TipRanks
Affimed to Present at the Cantor Global Healthcare Conference 2024 - GlobeNewswire
Affimed (NASDAQ:AFMD) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World
Cantor Fitzgerald Reiterates "Overweight" Rating for Affimed (NASDAQ:AFMD) - MarketBeat
Affimed (NASDAQ:AFMD) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Affimed N.V. (NASDAQ:AFMD) Q2 2024 Earnings Call Transcript - Insider Monkey
HC Wainwright Reaffirms Buy Rating for Affimed (NASDAQ:AFMD) - MarketBeat
Earnings call: Affimed reports promising clinical results and stable finances By Investing.com - Investing.com Australia
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):